Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas

       
Total article views   HTML views PDF downloads Totals
23,201 Dovepress* 18,836+ 1,507 20,343
PubMed Central* 4,365 933 5,298
Totals 23,201 2,440 25,641
*Since 6 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
36 1 0 0 12 23

View citations on PubMed and Google Scholar